Evaluation of Rotation With a Multifocal Toric Contact Lens

Sponsor
Johnson & Johnson Vision Care, Inc. (Industry)
Overall Status
Completed
CT.gov ID
NCT05433571
Collaborator
(none)
102
5
8
24
20.4
25.9

Study Details

Study Description

Brief Summary

The study is a bilateral, single-masked, single-visit, non-dispensing 2x2 crossover study to confirm a finalized design of a prototype contact lens. There will be eight study lens types, however, each subject will only be randomized to receive two study lens types.

Condition or Disease Intervention/Treatment Phase
  • Device: Test Lens
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
102 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
Single (Participant)
Primary Purpose:
Treatment
Official Title:
Evaluation of Rotation With a Multifocal Toric Contact Lens
Actual Study Start Date :
Jun 28, 2022
Actual Primary Completion Date :
Jul 22, 2022
Actual Study Completion Date :
Jul 22, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Myopes - Against the Rule Sequence 1

Eligible subjects that are habitual contact lens wearers will be randomized to the Myope, against-the-rule-astigmatism, (LOW/HIGH DC) sequence and wear two different study lens designs one at a time bilaterally over 2 wear periods.

Device: Test Lens
Multifocal Toric Contact Lenses manufactured in Senofilcon A (C3) material with UV/HEV filter

Experimental: Myopes - Against the Rule Sequence 2

Eligible subjects that are habitual contact lens wearers will be randomized to the Myope, against-the-rule-astigmatism, (HIGH/LOW DC) sequence and wear two different study lens designs one at a time bilaterally over 2 wear periods.

Device: Test Lens
Multifocal Toric Contact Lenses manufactured in Senofilcon A (C3) material with UV/HEV filter

Experimental: Myopes - With the Rule Sequence 1

Eligible subjects that are habitual contact lens wearers will be randomized to the Myope, with-the-rule-astigmatism, (LOW/HIGH DC) sequence and wear two different study lens designs one at a time bilaterally over 2 wear periods.

Device: Test Lens
Multifocal Toric Contact Lenses manufactured in Senofilcon A (C3) material with UV/HEV filter

Experimental: Myopes - With the Rule Sequence 2

Eligible subjects that are habitual contact lens wearers will be randomized to the Myope, with-the-rule-astigmatism, (HIGH/LOW DC) sequence and wear two different study lens designs one at a time bilaterally over 2 wear periods.

Device: Test Lens
Multifocal Toric Contact Lenses manufactured in Senofilcon A (C3) material with UV/HEV filter

Experimental: Hyperopes - Against the Rule Sequence 1

Eligible subjects that are habitual contact lens wearers will be randomized to the Hyperope, against-the-rule-astigmatism, (LOW/HIGH DC) sequence and wear two different study lens designs one at a time bilaterally over 2 wear periods.

Device: Test Lens
Multifocal Toric Contact Lenses manufactured in Senofilcon A (C3) material with UV/HEV filter

Experimental: Hyperopes - Against the Rule Sequence 2

Eligible subjects that are habitual contact lens wearers will be randomized to the Hyperope, against-the-rule-astigmatism, (HIGH/LOW DC) sequence and wear two different study lens designs one at time bilaterally over 2 wear periods.

Device: Test Lens
Multifocal Toric Contact Lenses manufactured in Senofilcon A (C3) material with UV/HEV filter

Experimental: Hyperope - With the Rule Sequence 1

Eligible subjects that are habitual contact lens wearers will be randomized to the Hyperope, with-the-rule-astigmatism, (LOW/HIGH DC) sequence and wear two different study lens designs one at a time bilaterally over 2 wear periods.

Device: Test Lens
Multifocal Toric Contact Lenses manufactured in Senofilcon A (C3) material with UV/HEV filter

Experimental: Hyperope - With the Rule Sequence 2

Eligible subjects that are habitual contact lens wearers will be randomized to the Hyperope, with-the-rule-astigmatism, (HIGH/LOW DC) sequence and wear two different study lens designs one at a time bilaterally over 2 wear periods.

Device: Test Lens
Multifocal Toric Contact Lenses manufactured in Senofilcon A (C3) material with UV/HEV filter

Outcome Measures

Primary Outcome Measures

  1. Absolute rotation ≤ 10° (Acceptable Absolute Rotation) [15-minutes after insertion]

    Absolute rotation less than or equal to 10° will be evaluated 15-minutes after insertion for each subject eye.

Eligibility Criteria

Criteria

Ages Eligible for Study:
40 Years to 70 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
Potential subjects must satisfy all of the following criteria to be enrolled in the study:
  1. Read, understand, and sign the STATEMENT OF INFORMED CONSENT and receive a fully executed copy of the form.

  2. Appear able and willing to adhere to the instructions set forth in this clinical protocol.

  3. Be at least 40 and not more than 70 years of age at the time of screening.

  4. Own a wearable pair of spectacles with distance vision correction.

  5. Be an adapted soft contact lens wearer in both eyes (i.e. has worn lenses a minimum of 2 days per week for at least 8 hours per wear day, for the past four weeks).

  6. Have distance spherical equivalent refraction in the range of either -1.00 D to -6.00 D or +1.00 to +6.00 D in each eye.

  7. Have distance cylinder refraction in the range of -0.75 to - 2.50 D in each eye, with the axis being in the range of either 90 ± 30° or 180 ± 30°.

  8. Have best corrected distance visual acuity of 20/25 or better in each eye.

Exclusion Criteria:

Potential subjects who meet any of the following criteria will be excluded from participating in the study:

  1. Be currently pregnant or lactating.

  2. Have any active or ongoing ocular or systemic allergies that may interfere with contact lens wear.

  3. Have any active or ongoing systemic disease, autoimmune disease, or use of medication, which may interfere with contact lens wear. This may include, but not be limited to, diabetes, hyperthyroidism, Sjögren's syndrome, xerophthalmia, acne rosacea, Stevens- Johnson syndrome, and immunosuppressive diseases or any infectious diseases (e.g. hepatitis, tuberculosis).

  4. Use systemic medications that may interfere with contact lens wear or cause blurred vision. See section 9.1 for additional details regarding excluded systemic medications.

  5. Currently use ocular medication with the exception of rewetting drops.

  6. Have any known hypersensitivity or allergic reaction to single use preservative free rewetting drops, or sodium fluorescein.

  7. Have had any previous ocular or intraocular surgery (e.g. radial keratotomy, PRK, LASIK, lid procedures, cataract surgery, retinal surgery, etc.).

  8. Have a history of amblyopia or strabismus.

  9. Have a history of herpetic keratitis.

  10. Have a history of irregular cornea.

  11. Have a history of pathological dry eye.

  12. Have participated in any contact lens or lens care product clinical trial within 14 days prior to study enrollment.

  13. Be an employee or immediate family member of an employee of clinical site (e.g., Investigator, Coordinator, Technician).

  14. Have clinically significant (Grade 3 or greater) corneal edema, corneal vascularization, corneal staining, tarsal abnormalities or bulbar injection, or any other corneal or ocular abnormalities which would contraindicate contact lens wear.

  15. Have entropion, ectropion, chalazia, recurrent styes, glaucoma, history of recurrent corneal erosions.

  16. Have any current ocular infection or inflammation.

  17. Have any other ocular abnormality that may interfere with contact lens wear

Contacts and Locations

Locations

Site City State Country Postal Code
1 Stam & Associates Eye Care Jacksonville Florida United States 32256
2 Sabal Eye Care Longwood Florida United States 32779
3 Maitland Vision Center - North Orlando Ave Maitland Florida United States 32751
4 Center for Ophthalmic and Vision Research/Eye Associates of New York Manhattan New York United States 10022
5 Tyler Eye Associates Tyler Texas United States 75703

Sponsors and Collaborators

  • Johnson & Johnson Vision Care, Inc.

Investigators

  • Study Director: Johnson & Johnson Vision Care, Inc. Clinical Trial, Johnson & Johnson Vision Care, Inc.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Johnson & Johnson Vision Care, Inc.
ClinicalTrials.gov Identifier:
NCT05433571
Other Study ID Numbers:
  • CR-6491
First Posted:
Jun 27, 2022
Last Update Posted:
Aug 9, 2022
Last Verified:
Aug 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
Yes
Product Manufactured in and Exported from the U.S.:
Yes

Study Results

No Results Posted as of Aug 9, 2022